GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » Other Current Payables

Acepodia (ROCO:6976) Other Current Payables : NT$55.12 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Acepodia Other Current Payables?

Acepodia's Other Current Payables for the quarter that ended in Jun. 2024 was NT$55.12 Mil.

Acepodia's quarterly Other Current Payables increased from Jun. 2023 (NT$44.29 Mil) to Dec. 2023 (NT$89.74 Mil) but then declined from Dec. 2023 (NT$89.74 Mil) to Jun. 2024 (NT$55.12 Mil).

Acepodia's annual Other Current Payables increased from Dec. 2021 (NT$68.54 Mil) to Dec. 2022 (NT$83.41 Mil) and increased from Dec. 2022 (NT$83.41 Mil) to Dec. 2023 (NT$89.74 Mil).


Acepodia Other Current Payables Historical Data

The historical data trend for Acepodia's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia Other Current Payables Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Payables
16.21 68.54 83.41 89.74

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Current Payables Get a 7-Day Free Trial - 83.41 44.29 89.74 55.12

Acepodia Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Acepodia Other Current Payables Related Terms

Thank you for viewing the detailed overview of Acepodia's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Acepodia Business Description

Traded in Other Exchanges
N/A
Address
17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia Headlines

No Headlines